Cholesterol metabolism shapes immune low-response states in LUAD: a multi-omics cholesterol metabolism signature predicts immunotherapy benefit and identifies DHCR7 as a therapeutic target

ABSTRACT:

SUBMITTER: Du M 

PROVIDER: S-EPMC12611822 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature